Literature DB >> 26173048

Independent Determinants of Maternal and Fetal Outcomes in a Sample of Pregnant Outpatients With Normal Blood Pressure, Chronic Hypertension, Gestational Hypertension, and Preeclampsia.

Arrigo F G Cicero1, Daniela Degli Esposti1, Vincenzo Immordino1, Martino Morbini1, Cristina Baronio1, Martina Rosticci1, Claudio Borghi1.   

Abstract

The aim of this retrospective study was to evaluate the main independent prognostic factors of negative maternal and fetal outcomes in a relatively large sample of pregnant outpatients (N=906) who were normotensive or affected by chronic hypertension, gestational hypertension, or preeclampsia. Among the studied parameters, the ones significantly associated with negative maternal outcomes were a diagnosis of preeclampsia (vs other forms of hypertension or normotension) and higher serum uric acid level, while antihypertensive treatment, number of previous deliveries, and blood pressure (BP) control at deliveries seemed to be protective. Regarding negative fetal outcomes, the parameters significantly associated with a negative maternal outcome were a diagnosis of preeclampsia (vs other forms of hypertension or normotension) and mother pre-pregnancy body mass index, while antihypertensive treatment and BP control at delivery seemed to be protective. Specific patient characteristics should help to predict the risk of negative maternal and fetal outcomes.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26173048      PMCID: PMC8031729          DOI: 10.1111/jch.12614

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  28 in total

1.  MOS HIP: McMaster outcome study of hypertension in pregnancy.

Authors:  J G Ray; R F Burrows; E A Burrows; M J Vermeulen
Journal:  Early Hum Dev       Date:  2001-09       Impact factor: 2.079

2.  Early predictors of gestational hypertension in a low-risk cohort. Results of a pilot study.

Authors:  Nieves Martell-Claros; Fiona Blanco-Kelly; María Abad-Cardiel; María J Torrejón; Beatriz Alvarez-Alvarez; Manuel E Fuentes; Dolores Ortega; Manuel Arroyo; Miguel A Herraiz
Journal:  J Hypertens       Date:  2013-12       Impact factor: 4.844

3.  Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia.

Authors:  Alan Buchbinder; Baha M Sibai; Steve Caritis; Cora Macpherson; John Hauth; Marshall D Lindheimer; Mark Klebanoff; Peter Vandorsten; Mark Landon; Richard Paul; Menachem Miodovnik; Paul Meis; Gary Thurnau
Journal:  Am J Obstet Gynecol       Date:  2002-01       Impact factor: 8.661

Review 4.  Antihypertensive drugs in pregnancy.

Authors:  Tiina Podymow; Phyllis August
Journal:  Semin Nephrol       Date:  2011-01       Impact factor: 5.299

5.  Uric Acid as a predictor of adverse maternal and perinatal outcomes in women hospitalized with preeclampsia.

Authors:  Joel R Livingston; Beth Payne; Mark Brown; James M Roberts; Anne-Marie Côté; Laura A Magee; Peter von Dadelszen
Journal:  J Obstet Gynaecol Can       Date:  2014-10

Review 6.  Antihypertensive drugs in pregnancy.

Authors:  R P Naden; C W Redman
Journal:  Clin Perinatol       Date:  1985-10       Impact factor: 3.430

7.  Treatment of hypertension in pregnancy with methyldopa: blood pressure control and side effects.

Authors:  C W Redman; L J Beilin; J Bonnar
Journal:  Br J Obstet Gynaecol       Date:  1977-06

Review 8.  Hyperuricemia and cardiovascular disease risk.

Authors:  Claudio Borghi; Federico Maria Verardi; Ilenia Pareo; Crescenzio Bentivenga; Arrigo F G Cicero
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-09-05

9.  Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study.

Authors:  Arrigo F G Cicero; Paolo Salvi; Sergio D'Addato; Martina Rosticci; Claudio Borghi
Journal:  J Hypertens       Date:  2014-01       Impact factor: 4.844

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  7 in total

Review 1.  Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question).

Authors:  Giorgina Barbara Piccoli; Gianfranca Cabiddu; Rossella Attini; Silvia Parisi; Federica Fassio; Valentina Loi; Martina Gerbino; Marilisa Biolcati; Antonello Pani; Tullia Todros
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

2.  Risk factors for adverse maternal and perinatal outcomes in women with preeclampsia: analysis of 1396 cases.

Authors:  Xun Li; Weishe Zhang; Jianhua Lin; Huai Liu; Zujing Yang; Yincheng Teng; Si Duan; Xinxiu Lin; Yingming Xie; Yuanqiu Li; Liangqun Xie; Qiaozhen Peng; Lu Xia
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-30       Impact factor: 3.738

3.  Maternal and Fetal Outcomes in Preeclampsia: Interrelations Between Insulin Resistance, Aldosterone, Metabolic Syndrome, and Polycystic Ovary Syndrome.

Authors:  Decio Armanini; Chiara Sabbadin; Gabriella Donà; Alessandra Andrisani; Guido Ambrosini; Luciana Bordin
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-14       Impact factor: 3.738

4.  Independent Determinants of Maternal and Fetal Outcomes in a Sample of Pregnant Outpatients With Normal Blood Pressure, Chronic Hypertension, Gestational Hypertension, and Preeclampsia.

Authors:  Arrigo F G Cicero; Daniela Degli Esposti; Vincenzo Immordino; Martino Morbini; Cristina Baronio; Martina Rosticci; Claudio Borghi
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-14       Impact factor: 3.738

Review 5.  Nutraceuticals and Hypertensive Disorders in Pregnancy: The Available Clinical Evidence.

Authors:  Silvia Fogacci; Federica Fogacci; Arrigo F G Cicero
Journal:  Nutrients       Date:  2020-01-31       Impact factor: 5.717

6.  Association between Serum Uric Acid Levels and Perinatal Outcome in Women with Preeclampsia.

Authors:  Robinson Uchenna Ugwuanyi; Irozuruike Munachiso Chiege; Felix Eke Agwu; George Uchenna Eleje; Nonso Martin Ifediorah
Journal:  Obstet Gynecol Int       Date:  2021-04-16

7.  Effectiveness and safety of 1 vs 4 h blood pressure profile with clinical and laboratory assessment for the exclusion of gestational hypertension and pre-eclampsia: a retrospective study in a university affiliated maternity hospital.

Authors:  Elizabeth Anne McCarthy; Thomas A Carins; Yolanda Hannigan; Nadia Bardien; Alexis Shub; Susan P Walker
Journal:  BMJ Open       Date:  2015-11-18       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.